Will we ever know the optimal duration of dual antiplatelet therapy after drug-eluting stent implantation?

JACC: Cardiovascular Interventions

Volumn 4, Issue 10, 2011, Pages 1129-1132

  Kastrati, Adnan ^a   Byrne, Robert A ^a   Schulz, Stefanie ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

antiplatelet therapy; clopidogrel; drug eluting stent(s)

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; EVEROLIMUS; PACLITAXEL; POLYMER; PRASUGREL; TICAGRELOR; ZOTAROLIMUS;

ATHEROSCLEROSIS; BARE METAL STENT; BLEEDING; CLINICAL PRACTICE; CORONARY ARTERY DISEASE; DEATH; DRUG ELUTING STENT; HEART INFARCTION; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; META ANALYSIS (TOPIC); NOTE; OPTICAL COHERENCE TOMOGRAPHY; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; STENT THROMBOSIS; STROKE; THROMBOSIS; THROMBOSIS PREVENTION; TREATMENT DURATION; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

EID: 80054979836     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2011.08.003     Document Type: Editorial

References (27)

1. G.W. Stone, S.G. Ellis, D.A. Cox TAXUS-IV Investigators A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease N Engl J Med 350 2004 221 231 (Pubitemid 38067635)
2. J.W. Moses, M.B. Leon, J.J. Popma SIRIUS Investigators Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323 (Pubitemid 37186209)
3. M. Joner, A.V. Finn, and A. Farb Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk J Am Coll Cardiol 48 2006 193 202 (Pubitemid 43929240)
4. A. Kastrati, J. Mehilli, and J. Pache Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents N Engl J Med 356 2007 1030 1039 (Pubitemid 46376803)
5. C. Stettler, S. Wandel, and S. Allemann Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis Lancet 370 2007 937 948 (Pubitemid 47393576)
6. L. Mauri, W.H. Hsieh, J.M. Massaro, K.K. Ho, R. D'Agostino, and D.E. Cutlip Stent thrombosis in randomized clinical trials of drug-eluting stents N Engl J Med 356 2007 1020 1029 (Pubitemid 46376802)
7. A. Schömig, F.J. Neumann, and A. Kastrati A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents N Engl J Med 334 1996 1084 1089 (Pubitemid 26120185)
8. C.L. Grines, R.O. Bonow, and D.E. Casey Jr. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians J Am Coll Cardiol 49 2007 734 739 (Pubitemid 46210116)
9. W. Wijns, P. Kolh, and N. Danchin Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Eur Heart J 31 2010 2501 2555
10. S.R. Mehta, S. Yusuf, R.J. Peters CURE Investigators Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study Lancet 358 2001 527 533 (Pubitemid 32772726)
11. S. Yusuf, F. Zhao, S.R. Mehta Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502 (Pubitemid 32758501)
12. S.R. Steinhubl, P.B. Berger, J.T. Mann 3rd CREDO Investigators Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial JAMA 288 2002 2411 2420 (Pubitemid 35340537)
13. D.E. Kandzari, C.S. Barker, and M.B. Leon Dual antiplatelet therapy duration and clinical outcomes following treatment with zotarolimus-eluting stents J Am Coll Cardiol Intv 4 2011 1119 1128
14. G. Ndrepepa, P.B. Berger, and J. Mehilli Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point J Am Coll Cardiol 51 2008 690 697 (Pubitemid 351221218)
15. F. Airoldi, A. Colombo, and N. Morici Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment Circulation 116 2007 745 754 (Pubitemid 47255992)
16. S. Schulz, T. Schuster, and J. Mehilli Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period Eur Heart J 30 2009 2714 2721
17. T. Kimura, T. Morimoto, Y. Nakagawa j-Cypher Registry Investigators Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation Circulation 119 2009 987 995
18. S.J. Park, D.W. Park, and Y.H. Kim Duration of dual antiplatelet therapy after implantation of drug-eluting stents N Engl J Med 362 2010 1374 1382
19. H.-C. Gwon, J.Y. Hahn, and Y.B. Song The randomized comparison of 6-month vs. 12-month duration of dual antiplatelet therapy after implantation of drug eluting stent Paper presented at: American College of Cardiology 2011 Scientific Sessions April 5, 2011 New Orleans, LA
20. D.L. Bhatt, K.A. Fox, W. Hacke CHARISMA Investigators Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events N Engl J Med 354 2006 1706 1717
21. A. Schömig, A. Dibra, and S. Windecker A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease J Am Coll Cardiol 50 2007 1373 1380 (Pubitemid 47449734)
22. P.C. Smits, E. Kedhi, and K.J. Royaards 2-Year follow-up of a randomized controlled trial of everolimus- and paclitaxel-eluting stents for coronary revascularization in daily practice COMPARE (Comparison of the Everolimus Eluting XIENCE-V Stent with the Paclitaxel Eluting Taxus LIBERTE Stent in All-Comers: a Randomized Open Label Trial) J Am Coll Cardiol 58 2011 11 18
23. S. Windecker, P.W. Serruys, and S. Wandel Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial Lancet 372 2008 1163 1173
24. R.A. Byrne, A. Kastrati, and S. Massberg Biodegradable polymer versus permanent polymer drug-eluting stents and everolimus-versus sirolimus-eluting stents in patients with coronary artery disease: three-year outcomes from a randomized clinical trial J Am Coll Cardiol 58 2011 1325 1331
25. S. Massberg, R.A. Byrne, A. Kastrati ISAR-TEST 5 Investigators Polymer-free sirolimus- and probucol-eluting versus new generation zotarolimus-eluting stents in coronary artery disease: the Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol-Eluting versus Zotarolimus-Eluting Stents (ISAR-TEST 5) trial Circulation 124 2011 624 632
26. S.D. Wiviott, E. Braunwald, C.H. McCabe TRITON-TIMI 38 Investigators Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015 (Pubitemid 350106708)
27. L. Wallentin, R.C. Becker, A. Budaj PLATO Investigators Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057